Lexeo Therapeutics (LXEO) Long-Term Debt Repayments (2022 - 2026)
Lexeo Therapeutics (LXEO) recorded Long-Term Debt Repayments of $142,000 in Q2 2026, up 16.4% from $122,000 a year earlier and up 17.4% from the prior quarter.
Lexeo Therapeutics (LXEO) Long-Term Debt Repayments (2022 - 2026) Analysis & Trends
On a TTM basis, Lexeo Therapeutics' Long-Term Debt Repayments came in at $515,000 as of Jun 30, 2026, up 1.4% year-over-year; for FY2025, it was $533,000, up 30.0% from FY2024.
- Annual Long-Term Debt Repayments has a three-year compound annual growth rate of 48.4% (FY2022 to FY2025).
- Across earlier years, Long-Term Debt Repayments came in at $410,000 in FY2024 (-3.5%), $425,000 in FY2023 (+160.7%) and $163,000 in FY2022.
- Quarterly Long-Term Debt Repayments has ranged from $36,000 in Q3 2022 to $169,000 in Q4 2025 over the past five years.
- On a year-over-year basis, Long-Term Debt Repayments rose in six of the last eight quarters, with growth averaging 17.2%.
- Peak year-over-year performance for Long-Term Debt Repayments in the last five years was growth of 197.2% in Q3 2023, against a decline of 28.2% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $121,000 (Q1 2026), $169,000 (Q4 2025) and $83,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Lexeo Therapeutics | 248.75 Mn | -411.66 Mn | - | 142,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142,000.00 |
| Mar 31, 2026 | 121,000.00 |
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 83,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 109,000.00 |
| Dec 31, 2023 | 105,000.00 |
| Sep 30, 2023 | 107,000.00 |
| Jun 30, 2023 | 103,000.00 |
| Mar 31, 2023 | 110,000.00 |
| Dec 31, 2022 | 108,000.00 |
| Sep 30, 2022 | 36,000.00 |
Lexeo Therapeutics Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=LXEO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();